CencoraWBO:ABC -0.27%69 OCF Yield % is 4.08 as of Jun. 26, 2026, which is 54% below its 10-year median of 8.91. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €259.45 (Fairly Valued). The stock has 1 warning sign investors should review. Among 119 Medical Distribution companies, Cencora ranks worse than 57.98% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Cencora OCF Yield % Related Terms
Cencora OCF Yield % Historical Data
* Premium members only.
The historical data trend for Cencora's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Cencora's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora OCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cencora's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Cencora's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora (WBO:ABC) has a OCF Yield % of 4.08 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cencora and its competitors. This is 54% below median its historical median of 8.91. According to the industry distribution chart, Cencora ranks #69 out of 119 companies in the Medical Distribution industry, placing it in the top 58%.
Is Cencora's OCF Yield % too high?
Cencora's current OCF Yield % of 4.08 is 54% below median its 10-year median of 8.91. The Medical Distribution industry median OCF Yield % is 5.98. Cencora's value of 4.08 is 31.8% below this industry median. Based on the distribution chart, Cencora ranks #69 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's OCF Yield % compare to CAH and MCK?
According to the Medical Distribution industry distribution chart, Cencora ranks #69 out of 119 companies for OCF Yield %. This places Cencora in the lower half of its industry. The industry median OCF Yield % is 5.98. Cencora's value of 4.08 is 31.8% below this benchmark. While the company's 10-year median is 8.91 vs. the industry median of 5.98, Cencora has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Distribution company?
The median OCF Yield % among Medical Distribution companies is 5.98, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cencora's current OCF Yield % of 4.08 is 31.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cencora and its competitors. For the Medical Distribution industry, the median OCF Yield % is 5.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cencora's current OCF Yield % is 4.08, which is 54% below median its own 10-year median of 8.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €259.45, compared to a current price of €254.30 — trading 2% below its estimated fair value. The current OCF Yield % is 4.08, which is 54% below median its 10-year median of 8.91 and 31.8% below the Medical Distribution industry median of 5.98. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Cencora (WBO:ABC), the current OCF Yield % is 4.08 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (WBO:ABC) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be undervalued.
The current stock price of €254.30 is trading 2% below its estimated GF Value™ of €259.45.
GuruFocus considers Cencora to be Fairly Valued.
Key valuation signals for WBO:ABC:
OCF Yield %: 4.08 (54% below median its 10-year median of 8.91)
GF Value™: €259.45 vs. price of €254.30 (2% below fair value)
Industry Position: 31.8% below the Medical Distribution median (#69 of 119)
No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
69GF Score
Get the complete analysis for WBO:ABC
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ABC has been successfully added to your 
